IP Library › Assignment 040779/0131
Patent Assignment
Reel/Frame 040779/0131

Assignment of Assignor's Interest

Recorded: 2016-12-28 Pages: 11
Assignors
O'BRIEN, CHRISTOPHER
Executed: 2015-10-18
ZANGRILLI, JAMES
Executed: 2015-10-19
SHAH, TUSHAR
Executed: 2015-10-19
Assignee
CEPHALON, INC.
41 MOORES ROAD, P.O. BOX 4011, FRAZER, PENNSYLVANIA, 19355
Covered Properties (5)
Use of Reslizumab To Treat Moderate to Severe Eosinophilic Asthma
Patent: 9,815,894 →
Application: 14/838,503 →
Publication: US 2016/0102144
Use of Reslizumab to Treat Moderate to Severe Eosinophilic Asthma
Application: 62/047,248 →
Use of Reslizumab to Treat Moderate to Severe Eosinophilic Asthma
Application: 62/091,150 →
Use of Reslizumab to Treat Moderate to Severe Eosinophilic Asthma
Application: 62/168,007 →
Use of Reslizumab to Treat Moderate to Severe Eosinophilic Asthma
Application: 62/191,690 →